Spark Therapeutics (ONCE) Misses Q3 EPS by 22c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. IVBIY

Go back to Spark Therapeutics (ONCE) Misses Q3 EPS by 22c

Spark Therapeutics Reports Third Quarter 2015 Financial Results and Recent Business Highlights

November 4, 2015 8:01 AM EST

Reported positive top-line results from pivotal Phase 3 trial of SPK-RPE65 for genetic blinding conditionsDurability of effect of SPK-RPE65 reported at three years with observation ongoingContinued progression and expansion of pipeline and operations

PHILADELPHIA, Nov. 04, 2015 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE) today announced financial results for the quarter ended September 30, 2015 and updated investors on its operational progress.

Last month we released positive Phase 3 data from... More